Rg1 attenuates NAFLD progression in D-galactose-induced murine models through targeted hepatoprotection, effectively mitigating steatotic accumulation, inflammatory cascades, and hepatocellular damage (Qi et al., 2020). This evidence concerns the gene PPP1R3A and metabolic dysfunction-associated steatotic liver disease.